1 year return (CAGR)
-88.65%
Apellis Pharmaceuticals Inc Exchange (NASDAQ, USD)
APLS
3.12
-0.02 (-0.52%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-57.34%
5 year return (CAGR)
-45.26%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
403.91M
Price/Sales
0.37
Ent value
664.79M
Price/Book
0.97
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
3.03
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.17 |
| Daily high | 3.17 |
| Daily low | 3.15 |
| Daily Volume | 1K |
| All-time high | 93.31 |
| 1y analyst estimate | 40.92 |
| Beta | -0.25 |
| EPS (TTM) | 1.06 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| APLS | S&P500 | |
| Current price drop from All-time high | -96.66% | -0.61% |
| Highest price drop | -96.73% | -56.47% |
| Date of highest drop | 29 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -39.15% | -10.68% |
| Avg time to new high | 35 days | 12 days |
| Max time to new high | 810 days | 1805 days |
News
No items found